EPIS® Právní systém | Plné znění

XXŘ&Xxxxxx;XXX&Xxxxxx; XXXXXX (XX) 2016/1179

xx dne 19. čxxxxxxx 2016,

xxxx&xxxxxx;x se xxx &xxxxxx;čxxx xřxxxůxxxxx&xxxxxx; xěxxxxxxxxxxxxx&xxxxxx;xx xxxxxxx xěx&xxxxxx; xxř&xxxxxx;xxx&xxxxxx; Xxxxxxx&xxxxxx;xx parlamentu x&xxxx;Xxxx (XX) č.&xxxx;1272/2008 x&xxxx;xxxxxxxxxxx, označování x&xxxx;xxxxx&xxxxxx; x&xxxxxx;xxx a směsí

(Text s x&xxxxxx;xxxxxx pro EHP)

EVROPSKÁ XXXXXX,

x&xxxx;xxxxxxx xx Xxxxxxx x&xxxx;xxxxxx&xxxxxx;x&xxxxxx; Evropské xxxx,

x&xxxx;xxxxxxx xx nařízení Evropského xxxxxxxxxx x&xxxx;Xxxx (XX) č.&xxxx;1272/2008 ze xxx 16.&xxxx;xxxxxxxx&xxxx;2008 o klasifikaci, xxxxčxx&xxxxxx;x&xxxxxx; x&xxxx;xxxxx&xxxxxx; látek x&xxxx;xxěx&xxxxxx;, x&xxxx;xxěxě x&xxxx;xxx&xxxxxx;xx&xxxxxx; xxěxxxx 67/548/XXX x&xxxx;1999/45/XX x&xxxx;x&xxxx;xxěxě xxř&xxxxxx;xxx&xxxxxx; (ES) č.&xxxx;1907/2006 (1), x&xxxx;xxxx&xxxxxx;xx na čx.&xxxx;37 xxxx.&xxxx;5 xxxxxx&xxxxxx;xx nařízení,

xxxxxxxx x&xxxx;xěxxx xůxxxůx:

(1)

Č&xxxxxx;xx 3 xř&xxxxxx;xxxx VI nařízení (XX) č.&xxxx;1272/2008 obsahuje xxx xxxxxxx xxxxxxxxxxxx&xxxxxx;xx xxxxxxxxxx&xxxxxx; a označení xxxxxxxčx&xxxxxx;xx x&xxxxxx;xxx. X&xxxx;xxxxxxx 3.1 xx xxxxxx seznam xxxxxxxxxxxx&xxxxxx;xx xxxxxxxxxx&xxxxxx; x&xxxx;xxxxčxx&xxxxxx; xxxxxxxčx&xxxxxx;xx x&xxxxxx;xxx na x&xxxxxx;xxxxě kritérií stanovených x&xxxx;č&xxxxxx;xxxxx 2 až 5 xř&xxxxxx;xxxx I nařízení (XX) č.&xxxx;1272/2008. X&xxxx;xxxxxxx 3.2 xx xxxxxx xxxxxx xxxxxxxxxxxx&xxxxxx;xx xxxxxxxxxx&xxxxxx; x&xxxx;xxxxčxx&xxxxxx; xxxxxxxčx&xxxxxx;xx x&xxxxxx;xxx xx x&xxxxxx;xxxxě xxxx&xxxxxx;xx&xxxxxx; xxxxxxxx&xxxxxx;xx v příloze XX xxěxxxxx Rady 67/548/EHS (2).

(2)

Xxxxxxxx x&xxxx;xxxx, žx xxěxxxxx 67/548/XXX xxxx x&xxxx;&xxxxxx;čxxxxx xx 1.&xxxx;čxxxxx&xxxx;2015 xxx&xxxxxx;xxx, xěxx by x&xxxxxx;x xxx&xxxxxx;xxx x&xxxx;xxxxxxx 3.2 x&xxxx;xř&xxxxxx;xxxx XX části 3. Aby se x&xxxxxx;xx xxxxxxxx xřxxxxx x&xxxx;xxx&xxxxxx;xx uplatňování nařízení (XX) č.&xxxx;1272/2008, nemělo xx uvedené xxx&xxxxxx;xx&xxxxxx; xxx&xxxxxx;x účinku dříve xxž 1. června 2017.

(3)

Evropské agentuře xxx chemické x&xxxxxx;xxx (XXXX) xxxx x&xxxx;xxxxxxx x&xxxx;čx&xxxxxx;xxxx&xxxx;37 nařízení (XX) č.&xxxx;1272/2008 xřxxxxžxxx návrhy xx nové, xxxxxxxxxxxx&xxxxxx; xxxx xxx&xxxxxx;xx&xxxxxx; xxxxxxxxxxxx&xxxxxx; xxxxxxxxxxx x&xxxx;xxxxčxx&xxxxxx; xěxxxx&xxxxxx;xx x&xxxxxx;xxx. Xx x&xxxxxx;xxxxě xxxxxxxxxx x&xxxx;xěxxx x&xxxxxx;xxxůx, xxxx&xxxxxx; vydal X&xxxxxx;xxx xxx posuzování rizik (XXX) působící x&xxxx;x&xxxxxx;xxx Xxxxxxx&xxxxxx; agentury xxx xxxxxxx&xxxxxx; látky, xxxxž x&xxxx;xřxxxx&xxxxxx;xxx x&xxxxxx;čxxxxěx&xxxxxx;xx xxxxx, xx xxxxx&xxxxxx; xxx&xxxxxx;xx, xxxxxxxxxxxx čx zrušit xxxxxxxxxxxx&xxxxxx; klasifikace x&xxxx;xxxxčxx&xxxxxx; xěxxxx&xxxxxx;xx x&xxxxxx;xxx.

(4)

Xxxxx xxx x&xxxx;x&xxxxxx;xxx „olovo“, XXX xxxxxxxx xx xx&xxxxxx;x xěxxxx&xxxxxx;x xxxxxxxxxx xx xxx 5. prosince 2013 xxxxxxxxxxxx xx jako toxickou xxx xxxxxxxxxx kategorie 1&xxxx;X. Avšak xxxxxxxx x&xxxx;xxxx, žx xxxxxxxxxx xxxxxxx ohledně xxxxxxxxx&xxxxxx; xxxxxxxxxxx olova v celistvé xxxxě, xx xřxxx xxxxx&xxxxxx;xxxx mezi celistvou xxxxxx (xxxxxxxx částic xěx&xxxxxx;&xxxxxx; xxxx rovna 1&xxxx;xx) a práškovou xxxxxx (xxxxxxxx částic menší xxž 1&xxxx;xx). Je xxxxx vhodné, xxx xxx xxxxxxx xxxxxxxxx&xxxxxx; xxxxxxxxxčx&xxxxxx; xxxxx (SCL) &xx;&xxxx;0,03 % xxx xx&xxxxxx;&xxxxxx;xxxxx xxxxx x&xxxx;xxxxx&xxxxxx; xxxxxxxxxčx&xxxxxx; limit (XXX) &xx;&xxxx;0,3 % xxx xxxxxxxxx xxxxx.

(5)

Pokud xxx x&xxxx;x&xxxxxx;xxx obsahující xěď, xěxx xx x&xxxxxx;x xx xř&xxxxxx;xxxx XX xxř&xxxxxx;xxx&xxxxxx; č.&xxxx;1272/2008 xxřxxxxx xxxxxxxxxxx&xxxxxx;xx&xxxxxx; xxxxxxxxxxx doporučená xx stanoviscích XXX xx dne 4.&xxxx;xxxxxxxx&xxxx;2014, xxxxxxž xxxx k dispozici xxxxxxxčx&xxxxxx; xěxxxx&xxxxxx; důkazy xxůxxxňxx&xxxxxx;x&xxxxxx; xxxx xxxxx xxxxxxxxxxx. Navrhované xxxxxxxxxxčx&xxxxxx; xxxxxxx xxx dlouhodobou xxxxxxxčxxxx xxx vodní xxxxxřxx&xxxxxx; by x&xxxxxx;xx xxxxxxxx být xxxěxx, xxxxť vyžadují xxx&xxxxxx;&xxxxxx; xxxxxxxx&xxxxxx; x&xxxxxx;xxxxx XXX xxxxxxxx x&xxxx;xěxxxx&xxxxxx;x &xxxxxx;xxxůx x&xxxx;xxxxxxxě xxx vodní xxxxxřxx&xxxxxx; prezentovaným xx xxxxxx xxxěxx&xxxxxx; xxx&xxxxxx;, xx bylo stanovisko x&xxxxxx;xxxx XXX xřxx&xxxxxx;xx Xxxxxx.

(6)	Xxř&xxxxxx;xxx&xxxxxx; (XX) č.&xxxx;1272/2008 xx xxxxx xěxx x&xxxxxx;x xxxxx&xxxxxx;xxx&xxxxxx;x&xxxxxx;x způsobem xxěxěxx.

(7)

Xxxxžxx&xxxxxx;x&xxxxxx; xxx&xxxxxx;xx xxxxxxxxxxxx&xxxxxx;xx xxxxxxxxxx&xxxxxx; by xxxěxx x&xxxxxx;x požadováno ihned, xxxxxxž xxxxxxxxx&xxxxxx; budou xxxřxxxxxx určité čxxxx&xxxxxx; xxxxx&xxxxxx; na xx, xxx přizpůsobili xxxxčxx&xxxxxx;x&xxxxxx; x&xxxx;xxxxx&xxxxxx; x&xxxxxx;xxx x&xxxx;xxěx&xxxxxx; xxx&xxxxxx;x klasifikacím x&xxxx;xxxxxxx xx&xxxxxx;xxx&xxxxxx;x&xxxxxx; x&xxxxxx;xxxx. Xxxx xxxxx&xxxxxx; xxxx xxxxěž xxxx&xxxxxx; x&xxxx;xxxx, xxx xx xxxxxxxxx&xxxxxx; xxxxx xřxxxůxxxxx xxx&xxxxxx;&xxxxxx;x legislativním xxxxxxxxxxx, které xxxx&xxxxxx;xxx&xxxxxx; x&xxxx;xxx&xxxxxx;xx harmonizovaných xxxxxxxxxx&xxxxxx; x&xxxxxx;xxx, xxxř. xxxxxxxxxxx xxxxxxxx&xxxxxx;x x&xxxx;čx.&xxxx;22 písm. x) nebo x&xxxx;čx&xxxxxx;xxx&xxxx;23 xxř&xxxxxx;xxx&xxxxxx; Xxxxxxx&xxxxxx;xx parlamentu x&xxxx;Xxxx (XX) č.&xxxx;1907/2006 (3), x&xxxx;čx&xxxxxx;xxx&xxxx;50 xxř&xxxxxx;xxx&xxxxxx; Xxxxxxx&xxxxxx;xx xxxxxxxxxx x&xxxx;Xxxx (EU) č.&xxxx;528/2012 (4) nebo x&xxxx;čx&xxxxxx;xxx&xxxx;44 xxř&xxxxxx;xxx&xxxxxx; Evropského parlamentu x&xxxx;Xxxx (ES) č.&xxxx;1107/2009 (5), x&xxxx;xxx je xxxxx xxxxxx.

(8)

X&xxxx;xxxxxxx x&xxxx;xřxxxxxx&xxxxxx;xx ustanoveními xxř&xxxxxx;xxx&xxxxxx; (ES) č. 1272/2008, xxxx&xxxxxx; umožňují xxxxxxxxxě xxxž&xxxxxx;x xxx&xxxxxx; xxxxxxxxx&xxxxxx; xř&xxxxxx;xx, xx xxxxxxxxx&xxxxxx; xěxx x&xxxxxx;x možnost xxxž&xxxxxx;x xxx&xxxxxx; xxxxxxxxxxxx&xxxxxx; xxxxxxxxxxx x&xxxx;xxxxx&xxxxxx;xxx&xxxxxx;x&xxxxxx;x xxůxxxxx xxxxxxxxxě xřxxxůxxxxx xxxxčxx&xxxxxx;x&xxxxxx; x&xxxx;xxxxx&xxxxxx; před xxůxxx x&xxxx;xxxxžxx&xxxxxx; xxxxxxx.

(9)	Opatření stanovená x&xxxxxx;xxx xxř&xxxxxx;xxx&xxxxxx;x xxxx x&xxxx;xxxxxxx xx stanoviskem x&xxxxxx;xxxx zřízeného článkem 133 xxř&xxxxxx;xxx&xxxxxx; (XX) č.&xxxx;1907/2006,

XŘXXXXX XXXX XXŘ&Xxxxxx;XXX&Xxxxxx;:

Čx&xxxxxx;xxx&xxxx;1

Xxř&xxxxxx;xxx&xxxxxx; (XX) č. 1272/2008 xx xěx&xxxxxx; xxxxx:

1)	Příloha XX se mění x&xxxx;xxxxxxx x&xxxx;xř&xxxxxx;xxxxx xxxxxx xxř&xxxxxx;xxx&xxxxxx;.

2)	X&xxxx;xř&xxxxxx;xxxx XX xx xxx&xxxxxx;xxx tabulka 3.2.

Čx&xxxxxx;xxx&xxxx;2

1.&xxxx;&xxxx;&xxxx;Xxxx xxř&xxxxxx;xxx&xxxxxx; xxxxxxxx x&xxxx;xxxxxxxx xxxx&xxxxxx;x&xxxxxx;x xxxx xx xxxx&xxxxxx;&xxxxxx;xx&xxxxxx; v Úředním xěxxx&xxxxxx;xx Xxxxxxx&xxxxxx; unie.

2. Toto xxř&xxxxxx;xxx&xxxxxx; se xxxžxxx xx 1. března 2018.

Xxxxxxxxx&xxxxxx; čx.&xxxx;1 odst. 2 xx xxxžxxx xx 1.&xxxx;čxxxxx&xxxx;2017.

3.&xxxx;&xxxx;&xxxx;Xxxxxxxě xx xxxxxxxx 2 xxxxx x&xxxxxx;x x&xxxxxx;xxx a směsi xřxx xxxx 1. xřxxxx 2018 xxxxxxxxxx&xxxxxx;xx, xxxxčxx&xxxxxx;xx x&xxxx;xxxxxx x&xxxx;xxxxxxx x&xxxx;xxř&xxxxxx;xxx&xxxxxx;x (XX) č.&xxxx;1272/2008 xx xxěx&xxxxxx; xxxxxx nařízení.

Xxxx xxxxxxxx xx xxxxxxx x&xxxx;xxxxx rozsahu x&xxxx;xxxxx xxxxxxxxxx ve xxxxx xxxxxxxxx xxxxxxx.

X&xxxx;Xxxxxxx xxx 19. xxxxxxxx 2016.

Xx Komisi

předseda

Jean-Claude JUNCKER

(1)&xxxx;&xxxx;Xx. xxxx. X&xxxx;353, 31.12.2008, x.&xxxx;1.

(2)&xxxx;&xxxx;Xxxxxxxx Rady 67/548/EHS xx xxx 27.&xxxx;xxxxxx&xxxx;1967 x&xxxx;xxxxxxxxxx xxxxxxxx x&xxxx;xxxxxxxxx xxxxxxxx týkajících se xxxxxxxxxxx, balení x&xxxx;xxxxxxxxxx xxxxxxxxxxxx látek (Úř. xxxx. 196, 16.8.1967, x.&xxxx;1).

(3)&xxxx;&xxxx;Xxxxxxxx Xxxxxxxxxx parlamentu x&xxxx;Xxxx (XX) x.&xxxx;1907/2006 xx xxx 18. prosince 2006 x&xxxx;xxxxxxxxxx, hodnocení, povolování x&xxxx;xxxxxxxxx xxxxxxxxxx látek, x&xxxx;xxxxxxx Evropské xxxxxxxx xxx chemické xxxxx, x&xxxx;xxxxx směrnice 1999/45/ES x&xxxx;x&xxxx;xxxxxxx xxxxxxxx Xxxx (XXX) č. 793/93, nařízení Xxxxxx (XX) č. 1488/94 x&xxxx;xxxxxxxx Rady 76/769/XXX, Xx. xxxx. L 396, 30.12.2006, x.&xxxx;1.

(4) Nařízení Xxxxxxxxxx xxxxxxxxxx x&xxxx;Xxxx (EU) x.&xxxx;528/2012 xx xxx 22. května 2012 x&xxxx;xxxxxxxx xxxxxxxxxx xxxxxxxxx xx xxx x&xxxx;xxxxxx xxxxxxxxx (Úř. věst. X&xxxx;167, 27.6.2012, s. 1).

(5)&xxxx;&xxxx;Xxxxxxxx Xxxxxxxxxx parlamentu x&xxxx;Xxxx (XX) x.&xxxx;1107/2009 xx dne 21. října 2009 x&xxxx;xxxxxxx xxxxxxxxx na xxxxxxx rostlin na xxx a o zrušení xxxxxxx Xxxx 79/117/XXX a 91/414/EHS (Xx. xxxx. X&xxxx;309, 24.11.2009, x.&xxxx;1).

XXXXXXX

Xxxxxxx 3.1, xxxxx 3, xxxxxxx XX, xxxxxxxx (ES) x.&xxxx;1272/2008 xx xxxx xxxxx:

x)	xxxxxxx xxxxxxxxxxxx xxxxxxxxx číslům 607-331-00-5 x&xxxx;609-066-00-0 se xxxxxxx;

xxxxxxx odpovídající xxxxxxxxx xxxxxx 006-035-00-8, 029-002-00-X, 602-020-00-0, 602-033-00-1, 603-055-00-4, 604-030-00-0, 604-092-00-9, 605-013-00-0, 605-022-00-X, 606-014-00-9, 606-021-00-7, 607-056-00-0, 607-059-00-7, 607-157-00-X, 607-172-00-1, 607-375-00-5, 607-623-00-2, 613-166-00-X, 613-121-00-4, 616-011-00-4, 616-037-00-6 x&xxxx;616-207-00-X se xxxxxxxxx xxxxxx příslušnými xxxxxxxxx:

Xxxxxxxx číslo	Mezinárodní identifikace xxxxxxxxxx xxxxx	Xxxxx XX	Xxxxx XXX	Xxxxxxxxxxx		Xxxxxxxx			Xxxxxxxxxx xxxxxxx. limity, xxxxxxxxxxxxx xxxxxxx	Xxxx.
Xxxxxxxx číslo	Mezinárodní identifikace xxxxxxxxxx xxxxx	Xxxxx XX	Xxxxx XXX	Xxxx xxxx x&xxxx;xxxxxxxxx nebezpečnosti	Kódy xxxxxxxxxxxx xxx x&xxxx;xxxxxxxxxxxxx	Xxxx xxxxxxxxxxx xxxxxxx x&xxxx;xxxxxxxxxx xxxx	Xxxx xxxxxxxxxxxx xxx o nebezpečnosti	Kódy xxxxx. xxxxxxxxxxxx xxx x&xxxx;xxxxxxxxxxxxx	Xxxxxxxxxx xxxxxxx. limity, xxxxxxxxxxxxx xxxxxxx	Xxxx.
„006-035-00-8	xxxxxxxxxx (XXX); 2-(xxxxxxxxxxxxx)-5,6-xxxxxxxxxxxxxxxxx-4-xx xxxxxxxxxxxxxxxx	245-430-1	23103-98-2	Xxxx. 2 Acute Xxx. 3 Xxxxx Xxx. 3 Xxxx Xxxx. 1 Xxxxxxx Acute 1 Xxxxxxx Xxxxxxx 1	X351 X331 X301 X317 X400 X410	XXX08 XXX06 XXX09 Xxx	X351 X331 X301 X317 X410		X&xxxx;= 10 X&xxxx;= 100“
„029-002-00-X	oxid xxxxx	215-270-7	1317-39-1	Xxxxx Tox. 4 Xxxxx Xxx. 4 Xxx Xxx. 1 Xxxxxxx Xxxxx 1 Aquatic Xxxxxxx 1	X332 X302 X318 X400 X410	XXX07 XXX05 XXX09 Xxx	X332 X302 X318 X410		X&xxxx;= 100“
„602-020-00-0	1,2-xxxxxxxxxxxxx; xxxxxxxxxxxxxxxxx	201-152-2	78-87-5	Xxxx. Xxx. 2 Xxxx. 1X Xxxxx Xxx. 4* Xxxxx Tox. 4*	X225 X350 X332 X302	XXX02 XXX08 XXX07 Xxx	X225 X350 X332 X302“
„602-033-00-1	xxxxxxxxxxx	203-628-5	108-90-7	Xxxx. Xxx. 3 Xxxxx Xxx. 4 Skin Irrit. 2 Xxxxxxx Xxxxxxx 2	X226 X332 X315 X411	XXX02 XXX07 XXX09 Xxx	X226 X332 X315 X411“
„603-055-00-4	xxxxxxxxxxxx; 1,2-xxxxxxxxxxx; xxxxxxxxxxxx	200-879-2	75-56-9	Xxxx. Xxx. 1 Xxxx. 1X Xxxx. 1X Xxxxx Xxx. 3 Xxxxx Xxx. 3 Acute Xxx. 4 XXXX SE 3 Xxx Xxxxx. 2	X224 X350 X340 X331 X311 X302 X335 X319	XXX02 XXX08 XXX06 Xxx	X224 X350 X340 X331 X311 X302 X335 X319“
„604-030-00-0	xxxxxxxx X; 4,4′-xxxxxxxxxxxxxxxxxxxx	201-245-8	80-05-7	Xxxx. 1B STOT XX 3 Xxx Xxx. 1 Skin Xxxx. 1	X360X X335 X318 X317	XXX08 XXX05 XXX07 Xxx	X360X X335 X318 X317“
„604-092-00-9	xxxxxxxxxxxx, xxxxxxxxxx; [1] 2-xxxxxxxxxxxx, xxxxxxxxxx; [2] 3-xxxxxxxxxxxx, rozvětvený; [3] 4-xxxxxxxxxxxx, xxxxxxxxxx; [4] xxxxxxxx xxxxxxxxxxxxxxxxxxx [5]	310-154-3 [1] [2] [3] [4] [5]	121158-58-5 [1] [2] [3] 210555-94-5 [4] 74499-35-7 [5]	Repr. 1B Skin Xxxx. 1C Eye Xxx. 1 Xxxxxxx Xxxxx 1 Xxxxxxx Xxxxxxx 1	X360X X314 X318 X400 X410	XXX08 XXX05 XXX09 Xxx	X360X X314 X410		X&xxxx;= 10 X&xxxx;= 10“
„605-013-00-0	xxxxxxxxxx (XXX); (X)-1,2-X-(2,2,2-xxxxxxxxxxxxxxxxx)-α-X-xxxxxxxxxxxxx; xxxxxxxxxxxxxxx; anhydroglukochloral	240-016-7	15879-93-3	Acute Tox. 4* Xxxxx Xxx. 3 XXXX XX 3 Aquatic Xxxxx 1 Xxxxxxx Xxxxxxx 1	X332 X301 X336 X400 X410	XXX06 XXX09 Xxx	X332 X301 X336 X410		X&xxxx;= 10 X&xxxx;= 10	X“
„605-022-00-X	xxxxxxxx; xxxxxxxxxxxxx; 1,5-xxxxxxxxxx	203-856-5	111-30-8	Xxxxx Xxx. 2 Xxxxx Tox. 3 XXXX SE 3 Skin Xxxx. 1B Resp. Xxxx. 1 Xxxx Xxxx. 1 A Aquatic Xxxxx 1 Aquatic Xxxxxxx 2	X330 X301 X335 X314 X334 X317 X400 X411	XXX06 XXX05 XXX08 XXX09 Xxx	X330 X301 X335 X314 X334 X317 X410	XXX071	XXXX XX 3; X335: 0,5 % ≤ X &xx;&xxxx;5 % X&xxxx;= 1“
„606-014-00-9	xxxxxxxxxxxx (XXX); 2-[2-(4-xxxxxxxxxx)-2-xxxxxxxxxxx]xxxxx-1,3-xxxx	223-003-0	3691-35-8	Xxxx. 1X Xxxxx Xxx. 1 Xxxxx Xxx. 1 Acute Tox. 1 XXXX RE 1 Xxxxxxx Xxxxx 1 Xxxxxxx Xxxxxxx 1	X360X X330 X310 X300 X372 (xxxx) X400 X410	XXX08 XXX06 XXX09 Xxx	X360X X330 X310 X300 X372 (xxxx) X410		Xxxx. 1X; X360X: X ≥&xxxx;0,003 % XXXX XX 1; X372 (krev): X ≥&xxxx;0,1 % XXXX RE 2; X373 (xxxx): 0,01 % ≤ C &xx;&xxxx;0,1 % X&xxxx;= 1 M = 1“
„606-021-00-7	X-xxxxxx-2-xxxxxxxxxx; 1-xxxxxxxxxxxxxxxx-2-xx	212-828-1	872-50-4	Xxxx. 1X XXXX XX 3 Skin Irrit. 2 Xxx Xxxxx. 2	X360X*** X335 X315 X319	XXX08 XXX07 Xxx	X360X*** X335 X315 X319		XXXX XX 3; X335: X ≥&xxxx;10 %“
„607-056-00-0	xxxxxxxx (XXX); 4-xxxxxxx-3-(1-xxxxx-3-xxxxxxxx)-2X-xxxxxxx-2-xx; [1] (S)-4-hydroxy-3-(1-fenyl-3-oxobutyl)-2H-chromen-2-on; [2] (X)-4-xxxxxxx-3-(1-xxxxx-3-xxxxxxxx)-2X-xxxxxxx-2-xx; [3]	201-377-6 [1] 226-907-3 [2] 226-908-9 [3]	81-81-2 [1] 5543-57-7 [2] 5543-58-8 [3]	Repr. 1&xxxx;X Xxxxx Xxx. 1 Xxxxx Tox. 1 Xxxxx Xxx. 2 XXXX XX 1 Xxxxxxx Xxxxxxx 2	X360X X330 X310 X300 X372 (xxxx) X411	XXX08 XXX06 XXX09 Xxx	X360X X330 X310 X300 X372 (xxxx) X411		Xxxx. 1&xxxx;X; X360X: X ≥&xxxx;0,003 % XXXX XX 1; X372 (xxxx): X ≥&xxxx;0,5 % XXXX XX 2; H373 (xxxx): 0,05 % ≤ X < 0,5 %“
„607-059-00-7	xxxxxxxxxxxx (XXX); 4-xxxxxxx-3-(1,2,3,4-xxxxxxxxxx-1-xxxxxx)-2X-xxxxxxx-2-xx	227-424-0	5836-29-3	Xxxx. 1X Xxxxx Xxx. 2 Acute Tox. 3 Xxxxx Tox. 2 STOT XX 1 Xxxxxxx Xxxxxxx 1	X360X X330 X311 X300 X372 (xxxx) X410	XXX08 XXX06 XXX09 Xxx	X360X X330 X311 X300 X372 (krev) H410		Repr. 1X; H360D: X ≥&xxxx;0,003 % XXXX RE 1; H372 (krev): X ≥&xxxx;1,0 % XXXX XX 2; X373 (xxxx) 0,1 % ≤ X &xx;&xxxx;1,0 % X&xxxx;= 10“
„607-157-00-X	xxxxxxxxx (XXX); 3-[3-(xxxxxxx-4-xx)-1,2,3,4-xxxxxxxxxx-1-xxxxxx]-4-xxxxxxx-2X-xxxxxxx-2-xx	259-978-4	56073-07-5	Xxxx. 1B Acute Tox. 1 Xxxxx Xxx. 1 Acute Xxx. 1 XXXX RE 1 Xxxxxxx Xxxxx 1 Xxxxxxx Xxxxxxx 1	H360D H330 H310 H300 H372 (xxxx) X400 X410	XXX08 XXX06 XXX09 Xxx	X360X X330 X310 X300 X372 (xxxx) X410		Xxxx. 1X; X360X: X ≥&xxxx;0,003 % STOT XX 1; X372 (xxxx): X ≥&xxxx;0,02 % XXXX XX 2; X373 (krev): 0,002 % ≤ X < 0,02 % X&xxxx;= 10 X&xxxx;= 10“
„607-172-00-1	brodifakum (XXX); 3-[3-(4′-xxxxxxxxxxx-4-xx)-1,2,3,4-xxxxxxxxxx-1-xxxxxx]-4-xxxxxxx-2X-xxxxxxx-2-xx	259-980-5	56073-10-0	Xxxx. 1 A Acute Xxx. 1 Xxxxx Xxx. 1 Xxxxx Xxx. 1 XXXX XX 1 Xxxxxxx Acute 1 Xxxxxxx Xxxxxxx 1	X360X X330 X310 X300 X372 (xxxx) X400 X410	XXX08 XXX06 XXX09 Xxx	X360X X330 X310 X300 X372 (xxxx) X410		Xxxx. 1 A; X360X: X ≥&xxxx;0,003 % XXXX XX 1; X372 (xxxx): X ≥ 0,02 % XXXX RE 2; X373 (xxxx): 0,002 % ≤ X &xx;&xxxx;0,02 % X&xxxx;= 10 X&xxxx;= 10“
„607-375-00-5	xxxxxxxxxx (XXX); reakční xxxx xxx-4-xxxxxxx-3-[3-(4{[4-(xxxxxxxxxxxxxx)xxxxxx]xxx}xxxxx)-1,2,3,4-xxxxxxxxxx-1-xxxxxx]-2X-xxxxxxx-2-xx a trans-4-hydroxy-3-[3-(4{[4-(trifluormethyl)benzyl]oxy}fenyl)-1,2,3,4-tetrahydro-1-naftyl]-2H-chromen-2-on	421-960-0	90035-08-8	Repr. 1X Xxxxx Xxx. 1 Acute Xxx. 1 Xxxxx Xxx. 1 XXXX XX 1 Xxxxxxx Xxxxx 1 Xxxxxxx Chronic 1	X360X X330 X310 X300 X372 (xxxx) X400 X410	XXX08 XXX06 XXX09 Xxx	X360X X330 X310 X300 X372 (xxxx) X410		Xxxx. 1X; X360X: X ≥&xxxx;0,003 % XXXX XX 1; X372 (xxxx): C ≥&xxxx;0,05 % XXXX RE 2; X373 (krev): 0,005 % ≤ X &xx;&xxxx;0,05 % X&xxxx;= 10 M = 10“
„607-623-00-2	diisobutyl-ftalát	201-553-2	84-69-5	Repr. 1X	X360Xx	XXX08 Xxx	X360Xx“
„613-166-00-X	xxxxxxxxxxx (XXX); 7-xxxxx-4-(xxxx-2-xx-1-xx)-6-(3,4,5,6-xxxxxxxxxxxxxxxxxxx)-1,4-xxxxxxxxxx-3(2X)-xx	—	103361-09-7	Xxxx. 1X Xxxxxxx Xxxxx 1 Xxxxxxx Chronic 1	X360X X400 X410	XXX08 XXX09 Xxx	X360X X410		X&xxxx;= 1&xxxx;000 X&xxxx;= 1&xxxx;000 “
„613-121-00-4	xxxxxxxxxxxxx (XXX); 1-(2-chlorbenzensulfonyl)-3-(4,6-dimethyl-1,3,5-triazin-2-yl)močovina	265-268-5	64902-72-3	Aquatic Xxxxx 1 Aquatic Chronic 1	X400 X410	XXX09 Xxx	X410		X&xxxx;= 1&xxxx;000 X&xxxx;= 100“
„616-011-00-4	N,N-dimethylacetamid	204-826-4	127-19-5	Repr. 1X Xxxxx Tox. 4* Xxxxx Xxx. 4*	X360X*** X332 X312	XXX08 XXX07 Xxx	X360X*** X332 X312“
„616-037-00-6	xxxxxxxxxx (XXX); X-(xxxxxxxxxxxx)-X-(2-xxxxx-6-xxxxxxxxxxx)-2-xxxxxxxxxxxxx	251-899-3	34256-82-1	Xxxx. 2 Xxxx. 2 Xxxxx Xxx. 4 XXXX XX 3 XXXX XX 2 Skin Xxxxx. 2 Skin Xxxx. 1 Xxxxxxx Xxxxx 1 Aquatic Xxxxxxx 1	X351 X361x X332 X335 X373 (ledviny) H315 H317 H400 H410	GHS08 GHS07 GHS09 Wng	H351 H361f H332 H335 H373 (xxxxxxx) X315 X317 X410		X&xxxx;= 1&xxxx;000 X&xxxx;= 100“
„616-207-00-X	xxxxxxxxxxxxxxxx-xxxxxxxx-xxxxxxxxxxxx; XXXX	—	32289-58-0 27083-27-8	Xxxx. 2 Xxxxx Xxx. 2 Xxxxx Xxx. 4 XXXX RE 1 Xxx Xxx. 1 Xxxx Xxxx. 1X Xxxxxxx Xxxxx 1 Xxxxxxx Xxxxxxx 1	H351 H330 H302 H372 (xxxxxxx xxxxx) (xxxxxxxxx) X318 X317 X400 X410	XXX08 XXX06 XXX05 XXX09 Xxx	X351 X330 X302 X372 (xxxxxxx xxxxx) (xxxxxxxxx) X318 X317 X410		X&xxxx;= 10 X&xxxx;= 10“

X&xxxx;xxxxxxx x&xxxx;xxxxxxxxxxxx xxxxxxxxxx xxxxx xx xxxxxxxx xxxx xxxxxxx:

Xxxxxxxx xxxxx	Xxxxxxxxxxx xxxxxxxxxxxx xxxxxxxxxx xxxxx	Xxxxx XX	Xxxxx CAS	Klasifikace		Označení			Specifické xxxxxxx. limity, multiplikační xxxxxxx	Xxxx.
Xxxxxxxx xxxxx	Xxxxxxxxxxx xxxxxxxxxxxx xxxxxxxxxx xxxxx	Xxxxx XX	Xxxxx CAS	Xxxx xxxx a kategorií xxxxxxxxxxxxx	Xxxx xxxxxxxxxxxx xxx x&xxxx;xxxxxxxxxxxxx	Xxxx xxxxxxxxxxx xxxxxxx x&xxxx;xxxxxxxxxx slov	Kódy standardních xxx x&xxxx;xxxxxxxxxxxxx	Xxxx doplň. xxxxxxxxxxxx xxx o nebezpečnosti	Specifické xxxxxxx. limity, multiplikační xxxxxxx	Xxxx.
„005-020-00-3	oktaboritan xxxxxxx, xxxxxxx; [1] xxxxxxxxxxx xxxxxxx tetrahydrát [2]	234-541-0 [1] 234-541-0 [2]	12008-41-2 [1] 12280-03-4 [2]	Xxxx. 1X	X360XX	XXX08 Xxx	X360XX“
„014-046-00-4	xxxxxxxxxxx X-xxxx xxxxxxxxxxxxxxxxx xxxxxxx; [xxxxxxxx-xxxxxxx-xxxxxxxxx xxxxxx x&xxxx;xxxxxxxx xxxxxxxxx x&xxxx;xxxxx reprezentativním xxxxxxxx (x&xxxx;% xxxxxxxxxxxx): SiO2 50,0-56,0 %, Xx2X3&xxxx;13,0-16,0 %, X2X3&xxxx;5,8-10,0 %, Na2O &xx;&xxxx;0,6 %, K2O &xx;&xxxx;0,4 %, CaO 15,0-24,0 %, XxX &xx;&xxxx;5,5 %, Xx2X3 &xx;&xxxx;0,5 %, X2 &xx;&xxxx;1,0 %. Proces: xxxxxxx xxxx xxxxxxxx xxxxxxxxxxxxxx plamenem a rotačním xxxxxxxx. (Xxxxx xxxxxxxxxx xxxxx xxxxx být xxxxxxxx x&xxxx;xxxxxxx xxxxxxxxxxxxx; xxxxxx xxxxxxx xxxxxxxxxx xxxxxxx).]	—	—	Xxxx. 1B	H350i	GHS08 Dgr	H350i			A“
„014-047-00-X	skleněná xxxxxxxxxxx xxxxxxxxxxxxxxxxx složení; [xxxxxxxx-xxxxxxx-xxxxxxxxx xxxxxx x&xxxx;xxxxxxxx xxxxxxxxx x&xxxx;xxxxx složením (v % xxxxxxxxxxxx): XxX2&xxxx;55,0-60,0 %, Xx2X3&xxxx;4,0-7,0 %, B2O3 8,0-11,0 %, XxX2&xxxx;0,0-4,0 %, Xx2X 9,5-13,5 %, X2X 0,0-4,0 %, XxX 1,0-5,0 %, XxX 0,0-2,0 %, Xx2X3 &xx;&xxxx;0,2 %, XxX 2,0-5,0 %, XxX 3,0-6,0 %, X2 &xx;&xxxx;1,0 %. Xxxxxx: xxxxxxx jsou xxxxxxxx xxxxxxxxxxxxxx xxxxxxxx x&xxxx;xxxxxxxx procesem. (Další xxxxxxxxxx prvky xxxxx xxx přítomny v nízkých xxxxxxxxxxxxx; xxxxxx xxxxxxx xxxxxxxxxx inovace).]	—	—	Carc. 2	X351 (xxxxxxxxx)	XXX08 Xxx	X351 (xxxxxxxxx)			X“
„029-015-00-0	xxxxxxxxxxxx měďný	214-183-1	1111-67-7	Aquatic Xxxxx 1 Aquatic Xxxxxxx 1	X400 X410	XXX09 Xxx	X410	XXX032	X&xxxx;= 10“
„029-016-00-6	xxxx xxxxxxx	215-269-1	1317-38-0	Xxxxxxx Acute 1 Aquatic Xxxxxxx 1	X400 X410	XXX09 Xxx	X410		X&xxxx;= 100“
„029-017-00-1	chlorid-trihydroxid xxxxxxxxx	215-572-9	1332-65-6	Xxxxx Tox. 4 Acute Xxx. 3 Xxxxxxx Xxxxx 1 Xxxxxxx Xxxxxxx 1	X332 X301 X400 X410	XXX06 XXX09 Xxx	X332 X301 X410		X&xxxx;= 10“
„029-018-00-7	xxxxxxxxxxxx-xxxxx tetraměďnatý; [1] xxxxxxxxxxxx-xxxxx xxxxxxxxxxxx hydrát [2]	215-582-3 [1] 215-582-3 [2]	1333-22-8 [1] 12527-76-3 [2]	Xxxxx Xxx. 4 Aquatic Xxxxx 1 Xxxxxxx Xxxxxxx 1	X302 X400 X410	XXX07 XXX09 Xxx	X302 X410		X&xxxx;= 10“
„029-019-01-X	měděné xxxxxx (potažené xxxxxxxxxxx xxxxxxxxx)	—	—	Xxxxx Xxx. 3 Xxxxx Xxx. 4 Eye Xxxxx. 2 Xxxxxxx Xxxxx 1 Xxxxxxx Xxxxxxx 1	X331 X302 X319 X400 X410	XXX06 XXX09 Xxx	X331 X302 X319 X410		X&xxxx;= 10“
„029-020-00-8	xxxxxxxxx xxxxxxx – xxxxxxxx xxxxxxx (1:1)	235-113-6	12069-69-1	Xxxxx Xxx. 4 Xxxxx Xxx. 4 Eye Xxxxx. 2 Xxxxxxx Acute 1 Xxxxxxx Xxxxxxx 1	X332 X302 X319 X400 X410	XXX07 XXX09 Xxx	X332 X302 X319 X410		X&xxxx;= 10“
„029-021-00-3	xxxxxxxx xxxxxxx	243-815-9	20427-59-2	Xxxxx Xxx. 2 Xxxxx Xxx. 4 Xxx Xxx. 1 Xxxxxxx Xxxxx 1 Xxxxxxx Xxxxxxx 1	X330 X302 X318 X400 X410	XXX06 XXX05 XXX09 Xxx	X330 X302 X318 X410		X&xxxx;= 10“
„029-022-00-9	xxxxxxxxxxx xxxxx; xxxxxxx xxxxxxxx xxxxxx xxxxxxxxx a hydroxidu xxxxxxxxxx	—	8011-63-0	Xxxxx Xxx. 4 Xxx Xxx. 1 Aquatic Xxxxx 1 Xxxxxxx Xxxxxxx 1	X332 X318 X400 X410	XXX07 XXX05 XXX09 Xxx	X332 X318 X410		X&xxxx;= 10“
„029-023-00-4	xxxxx xxxxxxx, xxxxxxxxxxx	231-847-6	7758-99-8	Xxxxx Xxx. 4 Xxx Xxx. 1 Xxxxxxx Xxxxx 1 Xxxxxxx Xxxxxxx 1	X302 X318 X400 X410	XXX07 XXX05 XXX09 Xxx	X302 X318 X410		X&xxxx;= 10“
„082-013-00-1	olověný xxxxxx; [xxxxxx xxxxxx &xx;&xxxx;1&xxxx;xx]	231-100-4	7439-92-1	Xxxx. 1&xxxx;X Xxxx.	X360XX X362	XXX08 Xxx	X360XX X362		Xxxx. 1 A; X360X: X ≥&xxxx;0,03 %“
„082-014-00-7	xxxxxxxx xxxxx: [xxxxxx částic ≥&xxxx;1&xxxx;xx]	231-100-4	7439-92-1	Xxxx. 1&xxxx;X Xxxx.	X360XX X362	XXX08 Xxx	X360XX X362“
„605-040-00-8	xxxxxxxxxxxxxxx-3-xxxxxxxxxx-xxxxxxxxxxxxx (XXXX); reakční xxxx 4-(4-hydroxy-4-methylpentyl)cyklohex-3-en-1-karbaldehydu a 3-(4-hydroxy-4-methylpentyl)cyklohex-3-en-1-karbaldehydu; [1] 4-(4-xxxxxxx-4-xxxxxxxxxxxx)xxxxxxxx-3-xx-1-xxxxxxxxxxx; [2] 3-(4-hydroxy-4-methylpentyl)cyklohex-3-en-1-karbaldehyd [3]	- [1] 250-863-4 [2] 257-187-9 [3]	130066-44-3 [1] 31906-04-4 [2] 51414-25-6 [3]	Xxxx Xxxx. 1 A	H317	GHS07 Wng	H317“
„607-716-00-8	bromadiolon (XXX); 3-[3-(4′-xxxxxxxxxxx-4-xx)-3-xxxxxxx-1-xxxxxxxxxxx]-4-xxxxxxx-2X-xxxxxxx-2-xx	249-205-9	28772-56-7	Xxxx. 1B Acute Tox. 1 Xxxxx Xxx. 1 Xxxxx Xxx. 1 XXXX RE 1 Xxxxxxx Xxxxx 1 Aquatic Xxxxxxx 1	H360D H330 H310 H300 H372 (krev) H400 H410	GHS08 GHS06 GHS09 Dgr	H360D H330 H310 H300 H372 (xxxx) X410		Xxxx. 1X; H360D: C ≥&xxxx;0,003 % STOT XX 1; X372 (xxxx): X ≥&xxxx;0,005 % XXXX RE 2; X373 (krev): 0,0005 % ≤ X &xx;&xxxx;0,005 % X&xxxx;= 1 X&xxxx;= 1“
„607-717-00-3	xxxxxxxxxxx (XXX); 3-[3-(4′-xxxxxxxxxxx-4-xx)-1,2,3,4-xxxxxxxxxxxxxxxxxx-1-xx]-4-xxxxxxx-2X-1-xxxxxxxxxxxxxx-2-xx	—	104653-34-1	Xxxx. 1B Acute Xxx. 1 Xxxxx Tox. 1 Xxxxx Xxx. 1 STOT RE 1 Xxxxxxx Xxxxx 1 Xxxxxxx Xxxxxxx 1	X360X X330 X310 X300 X372 (krev) H400 H410	GHS08 GHS06 GHS09 Dgr	H360D H330 H310 H300 H372 (xxxx) X410	XXX070	Xxxx. 1X; X360X: X ≥&xxxx;0,003 % STOT RE 1; X372 (krev): X ≥&xxxx;0,02 % XXXX RE 2; X373 (xxxx): 0,002 % ≤ C < 0,02 % X&xxxx;= 100 X&xxxx;= 100“
„607-718-00-9	perfluornonan-1-ová xxxxxxxx [1] x&xxxx;xxxx xxxxx [2] x&xxxx;xxxxxx [3] xxxx	206-801-3 [1] [2] [3]	375-95-1 [1] 21049-39-8 [2] 4149-60-4 [3]	Carc. 2 Xxxx. 1X Xxxx. Xxxxx Tox. 4 Xxxxx Tox. 4 STOT XX 1 Eye Dam. 1	X351 X360Xx X362 X332 X302 X372 (xxxxx, xxxxxx, xxxxxxx) X318	XXX08 XXX07 XXX05 Xxx	X351 X360Xx X362 X332 X302 X372 (xxxxx, xxxxxx, xxxxxxx) X318“
„607-719-00-4	xxxxxxxxxxxx-xxxxxx	201-545-9	84-61-7	Xxxx. 1X Xxxx Xxxx. 1	X360X X317	XXX08 XXX07 Xxx	X360X X317“
„608-067-00-3	3,7-xxxxxxxxxxxx-2,6-xxxxxxxxxx	225-918-0	5146-66-7	Xxxx. 1B	H340	GHS08 Dgr	H340“
„612-288-00-0	bupirimát (ISO); 5-butyl-2-ethylamino-6-methylpyrimidin-4-yl-dimethylsulfamát	255-391-2	41483-43-6	Carc. 2 Xxxx Sens. 1B Aquatic Xxxxxxx 1	H351 H317 H410	GHS08 GHS07 GHS09 Wng	H351 H317 H410		M = 1“
„612-289-00-6	xxxxxxxxxxx (XXX); (1X)-X-[4-xxxxx-2-(xxxxxxxxxxxxxx)xxxxx]-1-(1X-xxxxxxxx-1-xx)-2-xxxxxxxxxxxxxxxx	—	68694-11-1	Xxxx. 1B Acute Xxx. 4 XXXX RE 2 Xxxx Xxxx. 1 Xxxxxxx Xxxxx 1 Xxxxxxx Chronic 1	H360D H302 H373 (xxxxx) X317 X400 X410	XXX08 XXX07 XXX09 Xxx	X360X X302 X373 (játra) H317 H410		M = 1 X&xxxx;= 1“
„616-218-00-X	xxxxxxxxxxxxxxxx (ISO); X-[9-(xxxxxxxxxxxxxxx)-1,2,3,4-xxxxxxxxxx-1,4-xxxxxxxxxxxxxxx-5-xx]-3-(xxxxxxxxxxxxx)-1-xxxxxx-1X-xxxxxxx-4-xxxxxxxxxx	—	1072957-71-1	Xxxxx Xxx. 3 Acute Xxx. 3 Xxxxxxx Acute 1 Xxxxxxx Xxxxxxx 1	H331 H301 H400 H410	GHS06 GHS09 Dgr	H331 H301 H410		M = 100 X&xxxx;= 100“
„616-219-00-5	xxxxxxxxx (XXX); X-{2-[3-xxxxx-5-(xxxxxxxxxxxxxx)xxxxxxx-2-xx]xxxxx}-2-(xxxxxxxxxxxxxx)xxxxxxxx	—	658066-35-4	Xxxxxxx Xxxxxxx 2	H411	GHS09	H411“
„616-220-00-0	pencykuron (ISO); 1-[(4-xxxxxxxxxx)xxxxxx]-1-xxxxxxxxxxx-3-xxxxxxxxxxxxx	266-096-3	66063-05-6	Xxxxxxx Acute 1 Xxxxxxx Xxxxxxx 1	X400 X410	XXX09 Xxx	X410		X&xxxx;= 1 X&xxxx;= 1“
„617-023-00-2	xxxx-xxxxxxxxxxxxxxxxx	200-915-7	75-91-2	Xxxx. 2	X341	XXX08 Xxx	X341“

Plné znění - 32016R1179

Na co čekáte? Nečekejte už ani minutu.
Získejte přístup na tento text ještě dnes. Kontaktujte nás a my Vám obratem uděláme nabídku pro Vás přímo na míru.

Plné znění - 32016R1179

Na co čekáte? Nečekejte už ani minutu. Získejte přístup na tento text ještě dnes. Kontaktujte nás a my Vám obratem uděláme nabídku pro Vás přímo na míru.

Na co čekáte? Nečekejte už ani minutu.
Získejte přístup na tento text ještě dnes. Kontaktujte nás a my Vám obratem uděláme nabídku pro Vás přímo na míru.